Literature DB >> 22407290

Respiratory liver motion estimation and its effect on scanned proton beam therapy.

Ye Zhang1, D Boye, C Tanner, A J Lomax, A Knopf.   

Abstract

Proton therapy with active scanning beam delivery has significant advantages compared to conventional radiotherapy. However, so far only static targets have been treated in this way, since moving targets potentially lead to interplay effects. For 4D treatment planning, information on the target motion is needed to calculate time-resolved dose distributions. In this study, respiratory liver motion has been extracted from 4D CT data using two deformable image registration algorithms. In moderately moving patient cases (mean motion range around 6 mm), the registration error was no more than 3 mm, while it reached 7 mm for larger motions (range around 13 mm). The obtained deformation fields have then been used to calculate different time-resolved 4D treatment plans. Averaged over both motion estimations, interplay effects can increase the D₅-D₉₅ value for the clinical target volume (CTV) from 8.8% in a static plan to 23.4% when motion is considered. It has also been found that the different deformable registration algorithms can provide different motion estimations despite performing similarly for the selected landmarks, which in turn can lead to differing 4D dose distributions. Especially for single-field treatments where no motion mitigation is used, a maximum (mean) dose difference (averaged over three cases) of 32.8% (2.9%) can be observed. However, this registration ambiguity-induced uncertainty can be reduced if rescanning is applied or if the treatment plan consists of multiple fields, where the maximum (mean) difference can decrease to 15.2% (0.57%). Our results indicate the necessity to interpret 4D dose distributions for scanned proton therapy with some caution or with error bars to reflect the uncertainties resulting from the motion estimation. On the other hand, rescanning has been found to be an appropriate motion mitigation technique and, furthermore, has been shown to be a robust approach to also deal with these motion estimation uncertainties.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407290     DOI: 10.1088/0031-9155/57/7/1779

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  14 in total

Review 1.  Current status and future prospects of multi-dimensional image-guided particle therapy.

Authors:  Shinichiro Mori; Silvan Zenklusen; Antje-Christin Knopf
Journal:  Radiol Phys Technol       Date:  2013-02-19

2.  Implementation of a target volume design function for intrafractional range variation in a particle beam treatment planning system.

Authors:  S Mori; T Inaniwa; K Miki; T Shirai; K Noda
Journal:  Br J Radiol       Date:  2014-08-29       Impact factor: 3.039

Review 3.  Proton beam therapy for tumors of the upper abdomen.

Authors:  Ann Raldow; James Lamb; Theodore Hong
Journal:  Br J Radiol       Date:  2019-08-23       Impact factor: 3.039

Review 4.  Proton therapy in the treatment of hepatocellular carcinoma.

Authors:  Francesco Dionisi; Daniele Scartoni; Francesco Fracchiolla; Irene Giacomelli; Benedetta Siniscalchi; Lucia Goanta; Marco Cianchetti; Giuseppe Sanguineti; Alberto Brolese
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

5.  Four-dimensional Monte Carlo simulations demonstrating how the extent of intensity-modulation impacts motion effects in proton therapy lung treatments.

Authors:  Stephen Dowdell; Clemens Grassberger; Harald Paganetti
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

6.  Interplay effects in proton scanning for lung: a 4D Monte Carlo study assessing the impact of tumor and beam delivery parameters.

Authors:  S Dowdell; C Grassberger; G C Sharp; H Paganetti
Journal:  Phys Med Biol       Date:  2013-05-20       Impact factor: 3.609

Review 7.  Advances in 4D treatment planning for scanned particle beam therapy - report of dedicated workshops.

Authors:  Christoph Bert; Christian Graeff; Marco Riboldi; Simeon Nill; Guido Baroni; Antje-Christin Knopf
Journal:  Technol Cancer Res Treat       Date:  2013-12-17

8.  Commissioning of an integrated platform for time-resolved treatment delivery in scanned ion beam therapy by means of optical motion monitoring.

Authors:  G Fattori; N Saito; M Seregni; R Kaderka; A Pella; A Constantinescu; M Riboldi; P Steidl; P Cerveri; C Bert; M Durante; G Baroni
Journal:  Technol Cancer Res Treat       Date:  2013-12-17

9.  4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients.

Authors:  Kai Dolde; Ye Zhang; Naved Chaudhri; Christian Dávid; Marc Kachelrieß; Antony John Lomax; Patrick Naumann; Nami Saito; Damien Charles Weber; Asja Pfaffenberger
Journal:  Radiat Oncol       Date:  2019-02-07       Impact factor: 3.481

10.  Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma.

Authors:  Luca Cozzi; Tiziana Comito; Antonella Fogliata; Ciro Franzese; Stefano Tomatis; Marta Scorsetti
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.